Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/97886

In Collections

This item can be found in the following collections:

Reichardt, P.; Demetri, G.; Kang, Y.K.; Blay, J.Y.; Joensuu, H.; Maki, R.; ... ; Casali, P. (2012)

Randomized phase 3 trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) - GRID trial

Article / Letter to editor
All authors
Reichardt, P.; Demetri, G.; Kang, Y.K.; Blay, J.Y.; Joensuu, H.; Maki, R.; Rutkowski, P.; Hohenberger, P.; Gelderblom, H.; Leahy, M.; Mehren, M. von; Schoffski, P.; Blackstein, M.; Cesne, A. le; Badalamenti, G.; Xu, J.; Nishida, T.; Laurent, D.; Kuss, I.; Casali, P.
Date
2012-10-31
Journal
Onkologie
Volume
35
Pages
168 - 168